The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Purpose. To examine the efficacy of ophthalmic rebamipide suspensions on ocular surface disorders induced by antiglaucoma eye drops. Patients and Methods. Forty eyes of 40 patients receiving latanoprost (0.005%) and timolol (0.5%) were included in this randomized prospective study. The patients were...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2015/689076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558592363855872 |
|---|---|
| author | Naoto Tokuda Yasushi Kitaoka Akiko Matsuzawa Junsuke Miyamoto Shinsuke Sakae Yasunari Munemasa Hitoshi Takagi |
| author_facet | Naoto Tokuda Yasushi Kitaoka Akiko Matsuzawa Junsuke Miyamoto Shinsuke Sakae Yasunari Munemasa Hitoshi Takagi |
| author_sort | Naoto Tokuda |
| collection | DOAJ |
| description | Purpose. To examine the efficacy of ophthalmic rebamipide suspensions on ocular surface disorders induced by antiglaucoma eye drops. Patients and Methods. Forty eyes of 40 patients receiving latanoprost (0.005%) and timolol (0.5%) were included in this randomized prospective study. The patients were randomly divided into two groups (n = 20): the rebamipide-treated group and control
group. Changes in intraocular pressure, tear film break-up time (TBUT), and corneal epithelial barrier function were evaluated at baseline, 4 weeks, and 8 weeks after rebamipide administration. Furthermore, superficial punctate keratopathy severity was evaluated by scoring the lesion area and density. Results. There was no significant difference in intraocular pressure before and after rebamipide treatment. However, corneal epithelial barrier function improved significantly 4 and 8 weeks after rebamipide treatment. TBUT was partially, but significantly, increased (P = 0.02) 8 weeks after rebamipide treatment, whereas no significant change was observed at 4 weeks. Additionally, a significant decrease in area and density of keratopathy was observed 8 weeks after rebamipide treatment but not at 4 weeks. The control group showed no significant difference compared to baseline. Conclusions. Our data suggests that rebamipide treatment may reduce the occurrence of drug-induced ocular surface disorder. |
| format | Article |
| id | doaj-art-60ccbb60f8594feeabe2e1317a2aa776 |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-60ccbb60f8594feeabe2e1317a2aa7762025-02-03T01:31:58ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/689076689076The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma PatientsNaoto Tokuda0Yasushi Kitaoka1Akiko Matsuzawa2Junsuke Miyamoto3Shinsuke Sakae4Yasunari Munemasa5Hitoshi Takagi6Department of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanDepartment of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanDepartment of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanDepartment of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanDepartment of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanDepartment of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanDepartment of Ophthalmology, St. Marianna University School of Medicine, Kanagawa 216-8511, JapanPurpose. To examine the efficacy of ophthalmic rebamipide suspensions on ocular surface disorders induced by antiglaucoma eye drops. Patients and Methods. Forty eyes of 40 patients receiving latanoprost (0.005%) and timolol (0.5%) were included in this randomized prospective study. The patients were randomly divided into two groups (n = 20): the rebamipide-treated group and control group. Changes in intraocular pressure, tear film break-up time (TBUT), and corneal epithelial barrier function were evaluated at baseline, 4 weeks, and 8 weeks after rebamipide administration. Furthermore, superficial punctate keratopathy severity was evaluated by scoring the lesion area and density. Results. There was no significant difference in intraocular pressure before and after rebamipide treatment. However, corneal epithelial barrier function improved significantly 4 and 8 weeks after rebamipide treatment. TBUT was partially, but significantly, increased (P = 0.02) 8 weeks after rebamipide treatment, whereas no significant change was observed at 4 weeks. Additionally, a significant decrease in area and density of keratopathy was observed 8 weeks after rebamipide treatment but not at 4 weeks. The control group showed no significant difference compared to baseline. Conclusions. Our data suggests that rebamipide treatment may reduce the occurrence of drug-induced ocular surface disorder.http://dx.doi.org/10.1155/2015/689076 |
| spellingShingle | Naoto Tokuda Yasushi Kitaoka Akiko Matsuzawa Junsuke Miyamoto Shinsuke Sakae Yasunari Munemasa Hitoshi Takagi The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients Journal of Ophthalmology |
| title | The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients |
| title_full | The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients |
| title_fullStr | The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients |
| title_full_unstemmed | The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients |
| title_short | The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients |
| title_sort | effect of rebamipide on ocular surface disorders induced by latanoprost and timolol in glaucoma patients |
| url | http://dx.doi.org/10.1155/2015/689076 |
| work_keys_str_mv | AT naototokuda theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT yasushikitaoka theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT akikomatsuzawa theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT junsukemiyamoto theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT shinsukesakae theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT yasunarimunemasa theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT hitoshitakagi theeffectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT naototokuda effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT yasushikitaoka effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT akikomatsuzawa effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT junsukemiyamoto effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT shinsukesakae effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT yasunarimunemasa effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients AT hitoshitakagi effectofrebamipideonocularsurfacedisordersinducedbylatanoprostandtimololinglaucomapatients |